| Mrs Ashton Farmer Layne, PA-C | |
|
2721 W Park Dr, Paducah, KY 42001-9058 | |
| (270) 554-7546 | |
| (270) 554-0316 |
| Full Name | Mrs Ashton Farmer Layne |
|---|---|
| Gender | Female |
| Speciality | Physician Assistant |
| Experience | 4 Years |
| Location | 2721 W Park Dr, Paducah, Kentucky |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285263681 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363A00000X | Physician Assistant | PA2679 (Kentucky) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Wellsprings Institute, Pllc | 4880587005 | 4 |
News Archive
Nearly half of all men in a new study about intimate partner violence in male couples report being victims of abuse.
Harvard University's Wyss Institute of Biologically Inspired Engineering and its collaborating institutions, the Harvard John A. Paulson School of Engineering and Applied Sciences, Dana-Farber Cancer Institute, and Harvard's Department of Stem Cell and Regenerative Biology, announce the formation of a new NIH-funded Immuno-Engineering to Improve Immunotherapy Center.
New research shows that exposure to harmful chemicals and drugs during critical developmental periods early in life may actually "reprogram" the way certain genes respond to the female hormone estrogen. This genetic reprogramming may determine whether people with a genetic predisposition for a disease actually develop the disease.
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
In the year following their first treatment, patients with head and neck cancer report declines in their physical quality of life but improvements in their mental health quality of life, according to a report in the March issue of Archives of Otolaryngology-Head & Neck Surgery.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Ashton Farmer Layne, PA-C 2721 W Park Dr, Paducah, KY 42001-9058 Ph: (270) 554-7546 | Mrs Ashton Farmer Layne, PA-C 2721 W Park Dr, Paducah, KY 42001-9058 Ph: (270) 554-7546 |
News Archive
Nearly half of all men in a new study about intimate partner violence in male couples report being victims of abuse.
Harvard University's Wyss Institute of Biologically Inspired Engineering and its collaborating institutions, the Harvard John A. Paulson School of Engineering and Applied Sciences, Dana-Farber Cancer Institute, and Harvard's Department of Stem Cell and Regenerative Biology, announce the formation of a new NIH-funded Immuno-Engineering to Improve Immunotherapy Center.
New research shows that exposure to harmful chemicals and drugs during critical developmental periods early in life may actually "reprogram" the way certain genes respond to the female hormone estrogen. This genetic reprogramming may determine whether people with a genetic predisposition for a disease actually develop the disease.
Hollis-Eden Pharmaceuticals, Inc., today reported preliminary results of its ongoing Phase I/II clinical trial with Apoptone® (HE3235) for hormone-resistant prostate cancer (also called castrate-resistant prostate cancer or CRPC). Presented at the Molecular Targets and Cancer Therapeutics Conference, which is co-sponsored by the AACR, NCI and EORTC, the poster is titled: "Results of preclinical and clinical Phase I/II open-label dose-ranging trial with HE3235, a synthetic adrenal hormone, in Castrate Resistant Prostate Cancer (CRPC)."
In the year following their first treatment, patients with head and neck cancer report declines in their physical quality of life but improvements in their mental health quality of life, according to a report in the March issue of Archives of Otolaryngology-Head & Neck Surgery.
› Verified 3 days ago
Derick Thomas, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 2605 Kentucky Ave Ste 102, Paducah, KY 42003 Phone: 270-228-3973 Fax: 270-359-5046 | |
Reagan Poe, PA Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 1903 Broadway St Ste B, Paducah, KY 42001 Phone: 270-444-8183 Fax: 270-444-8147 | |
Mrs. Thu-trang Cleo Thi King, PA Physician Assistant Medicare: Medicare Enrolled Practice Location: 2501 Kentucky Ave, Paducah, KY 42003 Phone: 270-575-2180 Fax: 270-575-8479 | |
Mr. Brandon Howard Morehead, PA-C Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 2520 New Holt Rd, Paducah, KY 42001 Phone: 270-556-1488 | |
Mrs. Linda Mae Moran, CERT SURG 1ST ASST Physician Assistant Medicare: Not Enrolled in Medicare Practice Location: 275 Wedgewood Place, Paducah, KY 42001 Phone: 270-442-7167 Fax: 270-442-7167 | |
Derek N Nance, PAC Physician Assistant Medicare: Medicare Enrolled Practice Location: 1530 Lone Oak Rd, Paducah, KY 42003 Phone: 270-444-2150 Fax: 270-444-2985 | |
Melinda P Garrett, PA-C Physician Assistant Medicare: Accepting Medicare Assignments Practice Location: 3101 Parisa Dr., Paducah, KY 42003 Phone: 270-444-8477 Fax: 270-444-8479 |